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Serogrouping and sulphonamide
sensitivity of Neisseria meningitidis
isolates from the south-western Cape
To the Editor: Neisseria meningitidis infections were first reported
from the south-western Cape Province in 1883. 1 Since then,
against a backdrop of a relatively low incidence with winter
exacerbation, epidemic periods have occurred at 10 - IS-year
intervals. During the 1978 - 1979 epidemic more than 95% of
isolates at Tygerberg Hospital were of serogroup B and only 5%
were resistant to sulphonamides.2 Seventy-seven per cent of
patients notified as suffering from meningococcal infections were
under 4 years of age.3 In this report we briefly describe the
pattern of serogrouping and sulphonamide resistance of N.
meningitidis for the period 1980 - 1987.
The information for this report was gathered from three sources.
Details of notifications of meningococcal disease occurring in the
Western Cape Health Region for 1987 were obtained from the
regional office of the Department of National Health and Popula-
tion Development. Details of meningococcal isolates and their
serogrouping and sulphonamide sensitivity were obtained from
the Orange Street Pathology Laboratory, Cape Town, and the
Department of Medical Microbiology, Tygerberg Hospital.
Meningococcal serogrouping and determination of sulphonamide
sensitivity at both laboratories were done by conventional micro-
biological techniques.4.5
The results of serogrouping of meningococcal isolates and testing
for sulphonamide resistance at Tygerberg Hospital and the Orange
Street Laboratory are combined in Table I and illustrate a fall in
the relative predominance of serogroup B isolates, an increase in
serogroup C isolates and a dramatic decline in sulphonamide
sensitivity. In 1987 71% of the serogroup A isolates, 72% of
serogroup B isolates and only 54% of serogroup C isolates were
from patients aged under 4 years. Also in 1987 a total of 178 cases
of meningococcal disease were notified to the regional office of the
Department of Health and Population Development, of which
70% were in children under 4 years of age.
TABLE I. N. MENINGITIDISSEROGROUPING AND
SULPHONAMIDE SENSITIVITY, 1980-1987
Serogroup Isolates
resistant to
A 8 C Others sulphonamides
No. % No. % No. %. No. % (%)
1980 0 76 97 2 3 0 18
1981 3 4 70 88 3 4 4 3 27
1982 2 7 24 89 1 4 0 26
1983 0 50 96 1 2 1 2 38
1984 12 5 63 76 7 8 1 1 14
1985 12 10 112 78 15 10 4 3 32
1986 16 10 121 76 16 10 5 3 34
1987 15 10 102 67 26 17 8 5 56
In the south-western Cape the serogroup B meningococcus has
been dominant for the past decade and remains so despite the
decline documented in this study. Since no effective vaccine
against the serogroup B meningococcus is available, the emergence
of one of the other serogroups to a position of dominance would
be of some importance, offering the possibility of vaccination
should a further epidemic outbreak occur.
During the 1978 - 1981 epidemic in the south-western Cape,
prophylactic sulphonamides were used on a large scale by local
health authorities and hospitals. It is possible that this has led to
the decline in sulphonamide sensitivity. Rifampicin is at present
prescribed locally for meningococcal prophylaxis, but is capable of
rapid induction of resistance in meningococci.6 Since rifampicin is
already used on a large scale for the treatment of tuberculosis in
Cape Town, the situation will have to be watched closely. Data
from the Orange Street Laboratory indicate that there are no
rifampicin-resistant meningococci in circulation at present.
SAMT VOL 76 21 OKT 1989 453
It has been suggested that a shift in the age distribution of
patients with meningococcal disease may be of importance in
predicting the occurrence of an epidemic.7 It is therefore of
interest that the decline in the proportion of notified patients aged
under 4 years from 77% in 1978 - 1980 to 70% in 1987 appears to
have occurred in conjunction with an increase in the relatively
older group C cases, supporting the contention that a change in
age distribution of patients may predict a change in the prevalent
serogroups rather than the onset of an epidemic.8
Since the completion of this report it has become evident that a
further epidemic phase may have commenced. In 1988, 485 cases
of meningococcal disease with 63 deaths were notified to the
regional office of the Department of Health and Population De-
velopment.
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Dementia:"aluminium - a weak link?
To the Editor: The item entitled 'Study supports dementia-
aluminium link' I requires comment. Although no reference is
quoted, it is obviously based on a report in The Lancet by Martyn
et a/. 2
Briefly, this work examined the relationship between aluminium
concentration in drinking water and a diagnosis of probable
Alzheimer's disease. The report elicited a considerable amount of
comment both in the editorial pages of The Lancet3 and in the
correspondence columns. It was criticised on a number of grounds,
including: (I) the extreme difficulty in obtaining sound epidemio-
logical evidence of an association between aluminium and any
illness;3 (il) no account was taken of the fact that drinking water is
a relatively unimportant source of aluminium ingestion compared
with food or food additives/·4 (iil) the use of information on
computed tomography request forms as a basis for making the
